| The direction of protein entry into the proteasome determines the variety of products and depends on the force needed to unfold its two termini D Berko, S Tabachnick-Cherny, D Shental-Bechor, P Cascio, S Mioletti, ... Molecular cell 48 (4), 601-611, 2012 | 66 | 2012 |
| Polyomavirus‐driven Merkel cell carcinoma: Prospects for therapeutic vaccine development S Tabachnick‐Cherny, T Pulliam, C Church, DM Koelle, P Nghiem Molecular carcinogenesis 59 (7), 807-821, 2020 | 44 | 2020 |
| Osmostress induces autophosphorylation of Hog1 via a C-terminal regulatory region that is conserved in p38α I Maayan, J Beenstock, I Marbach, S Tabachnick, O Livnah, D Engelberg Public Library of Science 7 (9), e44749, 2012 | 32 | 2012 |
| Characterization of immunosuppressive myeloid cells in Merkel cell carcinoma: correlation with resistance to PD-1 pathway blockade. S Tabachnick-Cherny, T Pulliam, HJ Rodriguez, X Fan, DS Hippe, ... Clinical Cancer Research, 2023 | 2 | 2023 |
| Polyglutamine-Related Aggregates Can Serve as a Potent Antigen Source for Cross-Presentation by Dendritic Cells S Tabachnick-Cherny, S Pinto, D Berko, C Curato, Y Wolf, Z Porat, ... The Journal of Immunology 205 (10), 2583-2594, 2020 | 2 | 2020 |
| INTRATUMORAL S100A8-TO-CD8 RATIO IN INFLAMED MERKEL CELL CARCINOMA TUMORS CORRELATES WITH RESPONSE TO PD-1 PATHWAY BLOCKADE S Tabachnick-Cherny, T Pulliam, HR Chevez, K Smythe, R Kulikauskas, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 10, A1034-A1034, 2022 | | 2022 |
| Defining myeloid cells in the tumor microenvironment of Merkel cell carcinoma and their role in resistance to immunotherapy S Tabachnick-Cherny, T Pullliam, K Smythe, P Nghiem Journal of Investigative Dermatology 142 (10), 2840, 2022 | | 2022 |
| Inhibition potentiates immunogenicity in Merkel cell carcinoma: a promising approach to overcome resistance to anti-PD-1 immunotherapy R Bhakuni, PH Goff, JH Lee, T Pulliam, S Tabachnick-Cherny, ... Journal of Investigative Dermatology 142 (10), 2837, 2022 | | 2022 |
| 848 Inhibition of ATR augments immunogenicity in merkel cell carcinoma: A promising approach to address resistance to anti-PD-1 immunotherapy R Bhakuni, P Goff, JH Lee, T Pulliam, S Tabachnick-Cherny, ... Journal of Investigative Dermatology 142 (8), S147, 2022 | | 2022 |
| 541 Characterization of myeloid cell subsets in the tumor microenvironment of merkel cell carcinoma S Tabachnick-Cherny, T Pulliam, K Smythe, P Nghiem Journal of Investigative Dermatology 142 (8), S92, 2022 | | 2022 |
| DNA Damage Response Inhibitors as Potentiators of Radiation and Immunogenicity in Merkel Cell Carcinoma PH Goff, R Bhakuni, T Pulliam, S Tabachnick-Cherny, CD Morningstar, ... International Journal of Radiation Oncology, Biology, Physics 111 (3), e247, 2021 | | 2021 |
